Insider trade

Director sold ~$594K of IDXX shares in the open market

Traded Feb 17, 2026 · Filed Feb 19, 2026

Idexx LaboratoriesIDXX

~$594K
Reported value · 945 sh @ $628.646: 1,167
Holds after · shares reported: -17.3%
stock since the trade · S&P 500 +11.9%, $626.17 → $517.75 on Oct 1

Why it stands out

A board member of Idexx Laboratories sold $594K of Idexx Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 17, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 19, 2026

Director$500K–$1M

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$594,070

Shares × reported transaction price

Timing vs results

15 days after results of Feb 2, 2026, 77 days before results of May 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $626.17 on Feb 17, 2026, 73% above its 52-week low and 18% below its high, after a 7% drop over the previous 30 trading days

52-week range $361.04 (Apr 8, 2025) to $766.68 (Nov 25, 2025), 65% of the way up, from 251 adjusted closes. 30 trading days earlier: $669.99 on Jan 2, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+3.3%	-0.5%	+3.8%
30 days	-9.0%	-4.9%	-4.0%
90 days	-13.0%	+7.7%	-20.7%
180 days	-11.6%	+11.6%	-23.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0000874716-26-000032
Filed / recorded: Feb 19, 2026, 11:00 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: IDEXX LABORATORIES INC /DE
Issuer CIK: 874716
Ticker: IDXX
Reporting person: Sophie V. Vandebroek
Relationship: Director
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 17, 2026
Transaction code: S
Shares / units: 945
Price per share: $628.646
Acquired / disposed: Disposed (D)
Shares owned after: 1,167
Ownership form: Direct
Amendment: No

Around the same time

7mo ago

197Shares · @ $505.53

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

7mo ago

197Derivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold7mo ago

~$1.12MReported value · 1,758 sh @ $634.5718

Idexx Laboratories's Executive Vice President sold $1.12M of Idexx Laboratories shares. Nobody planned it ahead of time.

Why it stands out Official record